CXI Healthcare Technology Group씨엑스아이
900120 · KOSDAQ · ₩900120 · 씨엑스아이
₩2,995▼ ₩235 (7.28%)End-of-day · Oct 26, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 30.0% | 30.0% | 43.0% | 39.4% | 28.0% | 20.9% |
| Operating margin | 16.9% | 16.9% | 27.2% | 10.0% | 6.2% | 4.3% |
| Net margin | 22.1% | 22.1% | 42.3% | 10.5% | 5.9% | 4.9% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −21.2% | −21.2% | 0.0% | −30.8% | −10.6% | — |
| Operating income growth | −51.0% | −51.0% | +172.7% | +11.0% | +28.2% | — |
| Net income growth | −58.8% | −58.8% | +302.1% | +23.2% | +8.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 2.6% | 2.6% | 6.6% | 1.8% | 1.5% | 1.4% |
| Return on assets | 2.5% | 2.5% | 6.6% | 1.8% | 1.5% | 1.3% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 0.5% | 0.5% | 0.6% | 0.9% | 2.2% | 3.5% |
| Net debt to equity | −40.7% | −40.7% | −33.2% | −22.7% | −15.7% | −6.8% |
| Current ratio | 11,047.3% | 11,047.3% | 7,303.4% | 4,339.3% | 1,143.6% | 500.6% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: CXI Healthcare Technology Group / 씨엑스아이 / 900120 / KRX:900120
Source: KRX statistical information